Endonovo Therapeutics, Inc. (OTCMKTS:ENDV – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. Endonovo Therapeutics shares last traded at $0.00, with a volume of 1,600 shares trading hands.
Endonovo Therapeutics Trading Up 100.0 %
Endonovo Therapeutics Company Profile
Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.
Featured Stories
- Five stocks we like better than Endonovo Therapeutics
- Investing In Automotive Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- 3 Healthcare Dividend Stocks to Buy
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- 3 Stocks to Consider Buying in October
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Endonovo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endonovo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
